For: | Li YR, Hu TH, Chen WC, Hsu PI, Chen HC. Screening and prevention of hepatitis C virus reactivation during chemotherapy. World J Gastroenterol 2021; 27(31): 5181-5188 [PMID: 34497443 DOI: 10.3748/wjg.v27.i31.5181] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i31/5181.htm |
Number | Citing Articles |
1 |
Tadesse Atanaw, Getu Girmay, Aragaw Zemene, Muluneh Assefa, Tewodros Eshetie, Gezahegn Bewket, Fikadu Alemiye, Debaka Belete, Nega Birhane, Miquel Vall-llosera Camps. Seroprevalence of hepatitis B and C viruses and some possible associated factors among cancer patients at the Oncology Treatment Center, Gondar, Northwest Ethiopia: A cross-sectional study. PLOS ONE 2024; 19(8): e0308161 doi: 10.1371/journal.pone.0308161
|
2 |
Essam Al Ageeli, Jawaher A. Abdulhakim, Mohammad H. Hussein, Maryam M. Alnoman, Samia S. Alkhalil, Peter P. Issa, Nader A. Nemr, Ahmed Abdelmaksoud, Dhaifallah A. Alenizi, Manal S. Fawzy, Eman A. Toraih. The HCV-Melanoma Paradox: First Multi-Cohort and Molecular Net-Work Analysis Reveals Lower Incidence but Worse Outcomes—Integrating Clinical, Real-World, and In Silico Data. Medicina 2024; 60(9): 1531 doi: 10.3390/medicina60091531
|
3 |
Jinyong Wang, Di Dai, Ying Wen. Repeated Hepatitis C Virus Recurrence in a Patient With a Prognosis of Ultimate Spontaneous Clearance: Relapse or Reinfection?. American Journal of Therapeutics 2023; 30(5): e470 doi: 10.1097/MJT.0000000000001602
|
4 |
Anna Maria Spera. Safety of direct acting antiviral treatment for hepatitis C in oncologic setting: A clinical experience and a literature review. World Journal of Hepatology 2022; 14(3): 525-534 doi: 10.4254/wjh.v14.i3.525
|
5 |
Yu-Ming Wang, Sheng-Dean Luo, Ching-Nung Wu, Shao-Chun Wu, Wei-Chih Chen, Yao-Hsu Yang, Tai-Jan Chiu. The Impact of Clinical Prognosis of Viral Hepatitis in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy. Biomedicines 2023; 11(11): 2946 doi: 10.3390/biomedicines11112946
|